LY4005130
DrugAdministered IV
NCT Number: NCT07533006
The purpose of this study is to evaluate how well LY4005130 works in participants with severe alopecia areata (hair loss) when compared with placebo, and how well it's tolerated and what side effects may occur. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
The study drug will be administered intravenously (IV) (into a vein in the arm).
The study will last approximately 48 weeks, including screening.
Interested in participating?
Request Info18 year–50 year
All sexes
Interventional
Phase 2
Kelowna Health and Memory Centre, Kelowna, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administered IV
Administered IV
Time frame: Week 24
Time frame: Week 24
Time frame: Baseline Through Week 20
Time frame: Baseline, Week 24
Scalp Biopsy
Contact information is provided by the study sponsor or research team.
Physicians interested in becoming principal investigators please contact
CONTACT
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
Eli Lilly and Company
Industry
A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Proof of Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Severe Alopecia Areata
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07733063
Alopecia, Alopecia Areata
Istanbul, Cerrahpasa Mahallesi, Turkey (Türkiye)
View Trial DetailsNCT06012240
Alopecia, Alopecia Areata
Birmingham, Alabama, United States
View Trial DetailsNCT07617597
Alopecia, Alopecia Areata
Asahikawa, Japan
View Trial DetailsNCT06747611
Alopecia, Alopecia Areata
Minneapolis, Minnesota, United States
View Trial Details